A look at Chromadex Corp’s (CDXC) recent performance gives investors their first glimpse of hope.

On Tuesday, Chromadex Corp (NASDAQ: CDXC) was 1.74% up from the session before settling in for the closing price of $7.46. A 52-week range for CDXC has been $1.32 – $7.85.

Consumer Defensive Sector giant saw their annual sales surged by 22.27% over the last five years. When this article was written, the company’s average yearly earnings per share was at 157.14%. With a float of $48.21 million, this company’s outstanding shares have now reached $74.98 million.

The firm has a total of 106 workers. Let’s measure their productivity. In terms of profitability, gross margin is 55.76%, operating margin of 2.42%, and the pretax margin is 1.47%.

Chromadex Corp (CDXC) Insider Activity

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Chromadex Corp stocks. The insider ownership of Chromadex Corp is 36.88%, while institutional ownership is 23.28%. The most recent insider transaction that took place on Nov 22 ’24, was worth 21,397. In this transaction Chief Financial Officer of this company bought 2,907 shares at a rate of $7.36, taking the stock ownership to the 2,907 shares. Before that another transaction happened on Aug 23 ’24, when Company’s Director sold 23,000 for $3.57, making the entire transaction worth $82,110. This insider now owns 0 shares in total.

Chromadex Corp (CDXC) Earnings and Forecasts

Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0 earnings per share (EPS) during the time that was better than consensus figure (set at -0.02) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 157.14% per share during the next fiscal year.

Chromadex Corp (NASDAQ: CDXC) Trading Performance Indicators

You can see what Chromadex Corp (CDXC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.32. Likewise, its price to free cash flow for the trailing twelve months is 146.03.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.02, a number that is poised to hit 0.02 in the next quarter and is forecasted to reach 0.13 in one year’s time.

Technical Analysis of Chromadex Corp (CDXC)

Analysing the last 5-days average volume posted by the [Chromadex Corp, CDXC], we can find that recorded value of 0.92 million was better than the volume posted last year of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 66.35%. Additionally, its Average True Range was 0.47.

During the past 100 days, Chromadex Corp’s (CDXC) raw stochastic average was set at 95.16%, which indicates a significant increase from 84.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.32% in the past 14 days, which was lower than the 104.88% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.77, while its 200-day Moving Average is $3.44. Now, the first resistance to watch is $7.84. This is followed by the second major resistance level at $8.10. The third major resistance level sits at $8.44. If the price goes on to break the first support level at $7.24, it is likely to go to the next support level at $6.90. Should the price break the second support level, the third support level stands at $6.64.

Chromadex Corp (NASDAQ: CDXC) Key Stats

There are 76,383K outstanding shares of the company, which has a market capitalization of 579.75 million. As of now, sales total 83,570 K while income totals -4,940 K. Its latest quarter income was 25,580 K while its last quarter net income were 1,880 K.